Cytek Biosciences CTKB
NASDAQ CTKB
$4.67 +0.05 (+1.08%)
As of: Sep 9, 2026 · 1:46 PM EDT

Cytek Biosciences (CTKB) FCF Margin Growth (3y) (2023 - 2026)

Analysis

Cytek Biosciences (CTKB) FCF Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 224.41 Bn 220.35 Bn 8.34 Bn 221.00
2 Danaher 144.30 Bn 139.96 Bn 3.61 Bn -682.00
3 Agilent Technologies 40.92 Bn 39.16 Bn 1.04 Bn -539.00
4 Illumina 31.43 Bn 30.26 Bn 770.00 Mn 896.00
5 Revvity 13.85 Bn 12.82 Bn 416.87 Mn 4,700.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 299.00
7 Bio-Rad Laboratories 10.07 Bn 8.46 Bn 345.80 Mn 93.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -304.00
9 10x Genomics 8.66 Bn 8.11 Bn 112.50 Mn 1,752.00
10 Cytek Biosciences 604.58 Mn 530.73 Mn 28.34 Mn 661.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 661.00
Mar 31, 2026 -1,746.00
Dec 31, 2025 -215.00
Sep 30, 2025 1,257.00
Jun 30, 2025 2,359.00
Mar 31, 2025 410.00
Dec 31, 2024 -876.00
Sep 30, 2024 2,414.00
Jun 30, 2024 2,804.00
Mar 31, 2024 168.00
Dec 31, 2023 -2,360.00
Sep 30, 2023 -1,844.00